Tag

Horizon 2020

  • Other News

    Reading Recommendations

    December 1, 2016
    anna_sauerbier-kopieby Anna Sauerbier   Research and Innovation performance and Horizon 2020 country participation
    http://ec.europa.eu/programmes/horizon2020/en/news/research-and-innovation-performance-and-horizon-2020-country-participation Health at a Glance: Chronic disease costs European economy €115B a year
    http://sciencebusiness.net/health/news/2016/health-at-a-glance-chronic-disease-costs-european-economy-115b-a-year/ Public-private European partnership (ROADMAP) paves the way for sustainable platform for the generation… Continue Reading
  • Executive Page

    President’s Page: The new Consensus Statement on European Brain Research

    April 1, 2016
    On March 18th, 2016 the ‘Consensus statement on European Brain Research’ (Morris et al., 2016) has been launched in Brussels at the Brussel office of the European Brain Council. Several organisations related to brain science, including the European Academy of Neurology, participated. The European Brain Council is uniting the European organisations of physicians for Neurology, Psychiatry, Neurosurgery, the scientists for both molecular and systemic Neurosciences and the European patient organisations for neurological and psychiatric diseases (see below 1).
  • Interviews

    Interview with Thomas Skordas of the DG for communication networks, content and technology, European Commission

    November 1, 2015
    "Horizon 2020 is the financial instrument implementing the Innovation Union, a Europe 2020 flagship initiative aimed at securing Europe's global competitiveness", Thomas Skordas. Elena Moro (EM): Can you briefly illustrate to the Neuropenews readers what are the FET – Future and Emerging Technologies – actions and which place do they take within the EC’s H2020 programme? Thomas Skordas (TS): FET – Future and Emerging Technologies – is part of the "Excellent Science" pillar of Horizon 2020. The other components of this pillar are the "European Research Council (ERC)", the "Marie Skłodowska-Curie actions" and the "Research infrastructures" actions. Altogether, these four components aim to reinforce, widen and extend the excellence of the Union's science base and ensure a supply of world-class research and talent pursuing to secure Europe's long term competitiveness and well-being.
  • Interviews

    Interview with Karin Sipido, President of Alliance for Biomedical Research in Europe

    September 1, 2015
    Elena Moro (EM):  Can you briefly introduce the Alliance for Biomedical Research in Europe (BioMed Alliance) to the Neuropenews readers? Karin Sipido (KS): The Alliance for Biomedical Research in Europe (BioMed Alliance) is a unique initiative representing 21 leading European biomedical societies that together include more than 400,000 researchers and health professionals across Europe.
  • Interviews

    Interview with Isidoros Karatzas, Head of the “Ethics and Research Integrity” sector at the European Commission

    May 1, 2015
    Gian Luigi Lenzi (GLL): Ethical standards are an important aspect of H2020. How did the EC decide on these standards and who took part in their definition? Isidoros Karatzas (IK): The ethics standards are based on, for example, the principles of the European Charter of Fundamental Rights, the European Convention of Human rights (Article 19, Horizon 2020 regulation). Also on the relevant principles that flow from specific European and National legislation such as data protection and privacy, clinical trials etc. The Sector also follows and participates in the dialogue with the responsible Member States structures, such as the national Bioethics Committees, the network of Research Ethics Committees etc.
  • Executive Page

    Working for European Neurology in Brussels

    December 1, 2014
    Neurological diseases are seriously affecting life quality of the patients. Many of these diseases are followed by life-long disabilities or the patients even need care for the rest of their lives. Our daily work for the patients with neurological diseases transfers for politicians into costs for the Society and a recent analysis has found the annual costs for neurological diseases in Europe to be >300.000 Mio €¹, which is more than the annual budget of the German government.
  • Executive Page

    On the brain challenge

    June 1, 2013
    The European Commission held two major events during May to celebrate the European Month of the Brain under the Presidency of the Republic of Ireland.